Lifestream and Polymer resolve patent wrangle:
This article was originally published in Clinica
Lifestream Technologies has reached a settlement in its patent infringement lawsuit filed against Polymer Technology Systems, a private developer of rapid cholesterol tests. In the agreement, Polymer is to make royalty payments to Lifestream for future sales of products incorporating the latter's HDL (high density lipoprotein) technology, the subject of the dispute. The resolution follows shortly after Lifestream won its appeal to have overturned an initial ruling that found Polymer not guilty of infringement.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.